Showing 451-460 of 1560 results for "".
Reacting to RET Inhibitors: A Look at Progression & the Future
https://reachmd.com/programs/project-oncology/reacting-to-ret-inhibitors-a-look-at-progression-the-future/12429/One starting on a RET inhibitor, what do patients need to know about treatment progression into the future?Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
https://reachmd.com/programs/project-oncology/study-shows-importance-of-comprehensive-genomic-profiling-for-nsclc/15463/What do we need to know about comprehensive genomic profiling and CGP-directed therapies for NSCLC patients?Getting to Know GRADE: A Comparative Study of T2D Treatment
https://reachmd.com/programs/diabetes-discourse/getting-to-know-grade-a-comparative-study-of-t2d-treatment/14216/An ancillary study from the landmark GRADE study explores the efficacy of different treatments for type 2 diabetes. What do we need to know about them?Neuromuscular Disease and Inherited Heart Diseases
https://reachmd.com/programs/clinicians-roundtable/neuromuscular-disease-and-inherited-heart-diseases/2524/How do inherited heart diseases impact neuromuscular diseases? Dr. Elizabeth McNally, cardiologist and world-renowned expert on heart disease genetics speaks with Dr. Bruce Bloom on inherited heart diseases and their impact on muscular dystrophies; discussing current treatments and the role of celType I diabetes - How close are we to a cure?
https://reachmd.com/programs/clinicians-roundtable/type-i-diabetes-how-close-are-we-to-a-cure/1020/Dr. Raghu Mirmira, Associate Professor of Medicine and Associate Director of the Diabetes and Hormone Center of Excellence at the University of Virginia School of Medicine in Charlottesville, VA is here to discuss his work with transcription factors, the timing of their expression, the genes they taThe Potential Link Between COVID-19 and Cancer Regression
https://reachmd.com/programs/clinicians-roundtable/the-potential-link-between-covid-19-and-cancer-regression/29454/Discover how RNA from the COVID-19 virus can play a surprising role in cancer regression.An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
https://reachmd.com/programs/spotlight-subcutaneous--cancer-immunotherapy/an-analysis-of-subcutaneous-versus-intravenous-atezolizumab-in-nsclc/32992/How does subcutaneous atezolizumab compare to intravenous? Here’s what a clinical trial determined after evaluating the two approaches side by side.TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
https://reachmd.com/programs/cme/trop2-adcs-for-metastatic-nsclc-setting-the-stage-for-future-use/14416/Are you as excited as we are to see how TROP2-targeted antibody-drug conjugates can help our patients?Accuracy of Online Estimates: An Update
https://modernaesthetics.com/topics/energy-based-devices/accuracy-of-online-estimates-an-update/35189/Slight discrepancies between online estimates and actual procedure costs do not have a significant impact on patients’ decision to undergo treatmentsFrom Assessment to Management: Tackling Catatonia in Schizophrenic Patients
https://reachmd.com/programs/neurofrontiers/from-assessment-to-management-tackling-catatonia-in-schizophrenic-patients/17871/Explore the typical presentation and treatment of schizophrenia patients with catatonic symptoms.